Post Reply
161-180 of 326
TBH for SMG observing TA, everytime there' s huge breakout there tends to be an immediate reversal and then up down for the next couple of days..
Today break out almost 12%, since i am contra player i sold off at 0.615 just to lock in profit.. had bought earlier at 0.575 with 0.61 TP by eod closing.
For contra players the risk is not worth it.. If i had the ammo to long this i definitely will. To all the longists here , i am sure you will all huat!
Closed 61.5c. It' s an uptrend stock.
You ok or not?
chinton86 ( Date: 21-Apr-2017 09:30) Posted:
|
Maybank KE just upgraded their TP to 78c.
News does not lie people.
Singapore Medical Group acquires earnings accretive paediatric clinics for S$25.3 million
&bull Five-year profit guarantee of minimum S$2.3 million per year provides clear earnings visibility
&bull Total consideration of S$25.3 million carries an implied valuation of 11.0x P/E, funded via the issuance of new shares at S$0.54/share and the payment of S$13.9 million in three tranches
&bull Welcomes two reputable paediatricians along with two paediatric clinics in Toa Payoh and Bishan, strengthening the Group&rsquo s focus on bringing top quality specialist care that is conveniently located and available for patients to access
&bull In the near-term, SMG will add two additional O& G specialists to its existing team of eight with further plans to aggressively scale the newly acquired paediatrics division in Singapore and Vietnam Singapore &ndash 20 April 2017, SGX-listed Singapore Medical Group (&ldquo SMG&rdquo or &ldquo the Group&rdquo ), a multidisciplinary specialist healthcare services provider with 29 clinics in Singapore has announced that it has entered into agreements to acquire two paediatric clinics.
The acquisition marks the Group&rsquo s initial foray into paediatrics, a highly complementary specialist vertical that will provide synergies and cross-selling opportunities to the Group&rsquo s burgeoning Obstetrics & Gynaecology (&ldquo O& G&rdquo ) segment. Coupled with the Group&rsquo s eight existing O& G doctors, the addition of two paediatricians will make SMG one of the largest specialist practitioners in the private sector dedicated towards women&rsquo s health and wellness, and now babies and children. Pursuant to the agreements, the Group will acquire the Children&rsquo s Clinic in Toa Payoh and the Kids Clinic located in Bishan. Led by the established Dr Heng Siok Kheng and Dr Oh Meng Choo respectively, the two paediatric clinics are located conveniently in prominent heartland locations. Both doctors will serve six year service agreements and are committed to identifying and mentoring talented paediatricians as the Group looks to grow this segment in the near-term. For a total consideration of S$25.3 million, this earnings accretive acquisition will be funded via the issuance of approximately 21,024,931 new shares at S$0.54/share1 and the payment of S$13.9 million in cash over three tranches2 . The deal also provides clear earnings visibility with a five-year minimum S$2.3 million per year profit guarantee. Based on the profit guarantee of S$2.3 million per year, the acquisition carries an implied Price-to-Earnings ratio of 11.0. Commenting on the Group&rsquo s latest initiative, Executive Director and CEO Dr. Beng Teck Liang said, &ldquo For the first time, we are starting to crystallise our intent to address key milestones in our patient&rsquo s journey from cradle and beyond. Starting with birth and paediatrics to areas such as health screening and specialist fields, our overall strategy is starting to take shape as we intend to address and follow our patients&rsquo lifelong journey in health and wellness.
As we strive to be a leading pan-Asian healthcare provider, paediatrics is a natural progression for the Group and propels us up the value chain in providing our O& G patients with comprehensive care for their children. This acquisition will provide us with an established base with reputable doctors who will focus on grooming the next generation of paediatricians. In line with our strategy to grow the number of O& G specialists under our wing, we have received commitments from two doctors who will be joining us in the coming months. As we aim to double our current team of eight O& G specialists, it is inevitable that we will need to expand our paediatrics arm. As such, we intend to aggressively add additional paediatric clinics and paediatricians in the near-term. This strategy extends into the region as we have also hired a paediatric leader in Vietnam to spearhead growth initiatives at our clinics in Ho Chi Minh City, Careplus Vietnam. Furthering our previous acquisition of Astra, which bears the hub and spoke model via its flagship clinic in Novena and outreach into prominent heartland locations, our two paediatric clinics will provide us with access to a larger patient pool. Additionally, this value-driven acquisition presents us with tremendous cross-selling opportunities within the full suite of ambulatory care services we provide in areas such as dermatology, aesthetics, orthopedic, diagnostic, radiology and other specialist services.&rdquo The cash consideration of S$13.9 million will be funded by internal resources, bank facilities, and the net proceeds of S$15.0 million from the placement of shares to Korea&rsquo s leading O& G specialist, CHA Healthcare Co. Ltd. on 15 March 2017.
eagleeyes1989 ( Date: 21-Apr-2017 14:39) Posted:
|
Next week will hit 0.7 . get it now while still cheap, dont miss out.
before trading halt the TP is 0.67 now after halt and after the massive news of new accquisitions you saying its time to sell? lol u ok not?
just loaded 30k more lots @ 0.575. I think will hit 0.61 today.
chinton86 ( Date: 21-Apr-2017 09:30) Posted:
|
I heard that when Singmed was at 40c
chinton86 ( Date: 21-Apr-2017 09:30) Posted:
|
It should be the time to sell.
Looks like will take out 60c resistance soon and head for the sky.
Wait for the next analyst upgrade to around 80+ cent. Akan datang.
Superb news. Earnings accretive acquisition of $2.3m/year funded at issuance of shares at 54c.
This means that they' re very likely to push the price even higher for the doctors to accept price of 54c.
$1 target coming closer and closer.
New acquisition
Highly like rights issue.
Trading halt. Likely good news lai liao.
wonder why it is going down now.. last week seemed like can breach 0.6 easily..
Robust results TP raised 14%
We have raised our TP 14% after rolling forward the valuation base year to FY18E, with an unchanged P/E of 27x, pegged to the average two-year forward mean of small-cap healthcare peers in Singapore. FY16 net profit was in line with our estimate, led by robust growth in two key segments: healthcare and newly-formed diagnostic & aesthetics. FY16 core earnings were SGD2.0m, up from a loss of SGD0.2m in FY15. Operating cash flows also improved, at SGD4.3m vs. SGD0.4m. The turnaround was more apparent, as 2H16 core earnings more than doubled from 1H16 to SGD1.3m. With the recently proposed capital injection and strategic tie up with CHA, a leading medical group in Asia, SMG is well-positioned to explore more growth opportunities across Asia.
Key segments delivered strong growth
Revenue and gross profit increased 34% and 54% YoY for FY16, driven by robust growth in the healthcare (+35% YoY) and the diagnostics and aesthetics segment (+32% YoY). To recap, SMG expanded its screening business in 2016 with the acquisition of Novena Radiology in Apr and Lifescan Imaging in Sep. Management has successfully turned around both entities and promotes cross-selling opportunities within SMG&rsquo s network. Under the healthcare segment, oncology, obstetrician and gynaecology (O& G) and health screening recorded healthy growth.
Growth drivers: M& A and overseas expansion
SMG completed the acquisition of the Astra Women&rsquo s Specialist Group this month. This is a chain of seven O& G clinics, with a strong track record in women&rsquo s health. With a profit guarantee of SGD4.6m pa over the next five years, the acquisition will be a major earnings contributor. For overseas expansion, SMG entered Vietnam in Jan-17 through a JV with CityClinic Asia Investments, which includes two clinics in Ho Chi Minh City. We expect this to contribute to earnings after its ramp-up phase. With the recent SGD15m proposed strategic placement to CHA Healthcare, SMG will pursue strategic projects in the area of women&rsquo s health and tap on the growing Korean community in ASEAN.' - by Maybank Kim Eng
Maybe tomorrow will have some research report coming out soon bah.
Record earnings for FY2016.
What is tp ? Not vested and wondering if too late already to step in.
What is tp ? Not vested and wondering if too late already to step in.
chinton86 ( Date: 26-Feb-2017 13:53) Posted:
|
Awaiting for full year result annoucement.
57.5 ...Nice closing
Will it fly today? Let see